← Back to Clinical Trials
Recruiting NCT06531473

Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures

Trial Parameters

Condition Urologic Diseases
Sponsor Northwestern University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 300
Sex MALE
Min Age 18 Years
Max Age 89 Years
Start Date 2024-03-04
Completion 2026-08-30
Interventions
HoLEP

Brief Summary

The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2j 50hz. These settings are conventional settings, but there is no literature to prove optimal laser settings. The investigators hypothesizes that utilization of higher laser settings may be associated with a clinically significant (defined as \> 10%) decrease in procedural time without any detrimental postoperative outcomes, and a utilization of lower laser settings may be associated with a clinically significant (defined as \>10%) reduction in postoperative irritative voiding symptoms without any detrimental postoperative outcomes.

Eligibility Criteria

Inclusion Criteria: * Males 18-89 who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms, that are typically caused by enlarged prostates Exclusion Criteria: * Prostates measurements over 200g * Patients who lack decisional capacity * Patients who are non-english speakers

Related Trials